Clinical Trial Update: The Lacosamide's Effect on Calcitonin Gene-related Peptide in Migraine Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update on lacosamide's effect on calcitonin gene-related peptide in migraine patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Lacosamide (Lacosamide)

Snippet

Sponsor: Kafrelsheikh University | Conditions: Effect of Drug, Migraine Disorders | Phase 3 | Status: COMPLETED